What is the global market size of the Medical Cannabis Market?

Global Medical Cannabis Market size was valued at USD 11.84 billion in 2021 and is poised to grow from USD 14.50 billion in 2022 to USD 60.04 billion by 2030, at a CAGR of 22.5% during the forecast period (2023-2030).

Who are the key vendors in the Global Medical Cannabis Market?

A variety of strategic initiatives are being developed by the major players to increase their market share and obtain an advantage over rivals. In order to diversify their product offerings and increase their expertise, they are also focusing on strategic efforts including mergers and acquisitions, partnerships, collaborations, funding, and investment rounds. 'Aurora Cannabis Inc. (Canada)', 'Canopy Growth Corporation (Canada)', 'GW Pharmaceuticals plc (UK)', 'Tilray, Inc. (Canada)', 'Aphria Inc. (Canada)', 'MedReleaf Corp. (Canada)', 'Cronos Group Inc. (Canada)', 'Maricann Group Inc. (Canada)', 'Emblem Corp. (Canada)', 'CannTrust Holdings Inc. (Canada)', 'Organigram Holdings Inc. (Canada)', 'Hexo Corp. (Canada)', 'Vivo Cannabis Inc. (Canada)', 'TerrAscend Corp. (Canada)', 'Harvest Health & Recreation Inc. (USA)', 'Curaleaf Holdings, Inc. (USA)', 'Trulieve Cannabis Corp. (USA)', 'Columbia Care Inc. (USA)', 'Green Thumb Industries Inc. (USA)', 'Cresco Labs Inc. (USA)', 'Acreage Holdings, Inc. (USA)'

Medical Cannabis Market Size, Share, Growth Analysis, By Application (Pain Management, Others), By Type (Flower, Concentrates), By Distribution Channel (Pharmacies, Online Retailers), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35I2169 | Region: Global | Published Date: August, 2024
Pages: 219 | Tables: 63 | Figures: 76

Medical Cannabis Market Regional Insights

In 2022, North America had the highest revenue share (76.1%). One of the major factors driving up demand for cannabis is the growing legalization of the drug in the United States. Furthermore, the use of cannabis for therapeutic purposes is now legal in 37 states and the District of Columbia in the United States. While ten other states have also made it legal to use cannabis for recreational purposes. For the first time in more than 50 years, the American government has authorized new marijuana research farmers.

Increasingly supportive government initiatives and support are expected to cause Asia Pacific to experience the fastest CAGR over the coming years. Along with the expansion of cannabis legalization, the cannabis market is undoubtedly impacted by rising disposable income, rising social acceptance, and growing public awareness of the benefits of the product.

Medical Cannabis Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Medical Cannabis Market size was valued at USD 14.50 billion in 2022 and is poised to grow from USD 17.76 billion in 2023 to USD 90.07 billion by 2031, growing at a CAGR of 22.50% in the forecast period (2024-2031).

A variety of strategic initiatives are being developed by the major players to increase their market share and obtain an advantage over rivals. In order to diversify their product offerings and increase their expertise, they are also focusing on strategic efforts including mergers and acquisitions, partnerships, collaborations, funding, and investment rounds. 'Aurora Cannabis Inc. (Canada) ', 'Canopy Growth Corporation (Canada) ', 'Cronos Group Inc. (Canada) ', 'Maricann Group Inc. (Canada) ', 'CannTrust Holdings Inc. (Canada) ', 'Organigram Holdings Inc. (Canada) ', 'Hexo Corp. (Canada) ', 'Vivo Cannabis Inc. (Canada) ', 'TerrAscend Corp. (Canada) ', 'Curaleaf Holdings, Inc. (USA) ', 'Trulieve Cannabis Corp. (USA) ', 'Green Thumb Industries Inc. (USA) ', 'Cresco Labs Inc. (USA) ', 'Acreage Holdings, Inc. (USA) ', 'Jazz Pharmaceuticals plc (Ireland) ', 'CV Sciences, Inc. (USA) ', 'MedMen Enterprises Inc. (USA) ', 'Khiron Life Sciences Corp. (Canada) ', 'Aurora Cannabis Inc. (Canada) ', 'Aleafia Health Inc. (Canada)'

Cannabis has now been given the green light to treat a number of conditions, including nausea and vomiting brought on by chemotherapy, restlessness, muscle tension, and chronic discomfort. Research into the possibilities of therapeutic cannabis and hemp is moving forward quickly for the majority of enterprises.

There is a growing trend towards the development of a wide range of cannabis-based products, including oils, tinctures, capsules, and topical creams. This diversification of products is helping to expand the market and attract a wider range of patients.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Medical Cannabis Market Size, Share, Growth Analysis, By Application (Pain Management, Others), By Type (Flower, Concentrates), By Distribution Channel (Pharmacies, Online Retailers), By Region - Industry Forecast 2024-2031

Medical Cannabis Market Regional Insights

Medical Cannabis Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Medical Cannabis Market?

Who are the key vendors in the Medical Cannabis Market?

What is the key driver of Medical Cannabis Market?

What is the key market trend for Medical Cannabis Market?

Which region accounted for the largest share in Medical Cannabis Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300